Synyi, a Shanghai-based artificial intelligence-powered medical solutions firm, has raised $36.32 million in its Series C funding led by China’s internet giant Tencent and healthcare private equity Sinopharm Capital.
Continue reading this premium story with a subscription to DealStreetAsia.Subscribe
Already a Subscriber? Log in
Contact us for corporate subscriptions at email@example.com